Cargando…
KLF9 regulates miR-338-3p/NRCAM axis to block the progression of osteosarcoma cells
Background: MiR-338-3p is revealed to serve as a tumor suppressor in several carcinomas. Whereas, the effect of miR-338-3p in the progression of osteosarcoma has not been explored. The aim of this paper was to analyze the functional influences of miR-338-3p on osteosarcoma progression and the potent...
Autores principales: | Liu, Yunlu, Han, Kuijing, Cao, Yulin, Hu, Yuxiang, Shao, Zengwu, Tong, Wei, Han, Yanjiu, Liu, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990415/ https://www.ncbi.nlm.nih.gov/pubmed/35399713 http://dx.doi.org/10.7150/jca.63533 |
Ejemplares similares
-
Silencing of lncRNA KLF3‐AS1 represses cell growth in osteosarcoma via miR‐338‐3p/MEF2C axis
por: Chen, Chunfa, et al.
Publicado: (2022) -
Ischemic Necrosis of Lower Extremity in COVID-19: A Case Report
por: Liu, Yunlu, et al.
Publicado: (2021) -
Cataracts and NrCAM
por: Dove, Alan W.
Publicado: (2001) -
miR-505 suppresses prostate cancer progression by targeting NRCAM
por: Ling, Xiao-Hui, et al.
Publicado: (2019) -
miR-505 suppresses prostate cancer progression by targeting NRCAM
por: Ling, Xiao-Hui, et al.
Publicado: (2020)